BAN2401
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The theory of amyloid-induced Alzheimer's disease(AD)has been challenged by the scientific community.However, with the deep study…
A new drug called BAN2401 has shown promise in decreasing amyloid in early AD, according to results from a phase II study.
Currently, several amyloid beta (Aβ) antibodies, including the protofibril selective antibody BAN2401, are in clinical trials…
METHODS Purpose: To develop a generic approach for quantitation of total (bound and free) therapeutic monoclonal antibodies (mAb…
In order to avoid Abeta-induced autoimmune encephalitis, several monoclonal and polyclonal antibodies are in clinical trials…
In order to avoid Abeta-induced autoimmune encephalitis, several monoclonal and polyclonal antibodies are in clinical trials…
アルツハイマー病の治療戦略としてアミロイドβ （Aβ）の生成や凝集を阻害すること，あるいはAβを除去することなどが考えられている．Aβを除去するという観点では，アミロイドβ免疫療法が最も妥当性が高いと考えられる．アミロイドβ免疫療法は，エラン社のDale…